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E-mail address: klionsky@umich.edu (D.J. KlionskyAutophagy is a highly conserved, ubiquitous process that is responsible for the degradation of cyto-
solic components in response to starvation. Autophagy is generally considered to be non-selective;
however, there are selective types of autophagy that use receptor and adaptor proteins to speciﬁ-
cally isolate a cargo. One type of selective autophagy in yeast is the cytoplasm to vacuole targeting
(Cvt) pathway. The Cvt pathway is responsible for the delivery of the hydrolase aminopeptidase I to
the vacuole; as such, it is the only known biosynthetic pathway that utilizes the core machinery of
autophagy. Nonetheless, it serves as a model for the study of selective autophagy in other organisms.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autophagy is a ubiquitous process that is highly conserved in all
eukaryotes. It is responsible for the degradation of cytosolic com-
ponents and organelles in response to nutrient deprivation [1,2].
In addition to playing a role in the cellular response to stress,
autophagy also plays a role in development [3], tumor suppression
[4], pathogen resistance [5], and aging [6]. We now know that this
process is involved in several human pathologies including cancer
[7], diabetes [8,9], cardiomyopathy [10], and neurodegenerative
disorders such as Alzheimer and Parkinson diseases [11].
There are three main types of autophagy; chaperone-mediated
autophagy, microautophagy, and macroautophagy (Fig. 1). Chaper-
one-mediated autophagy has only been characterized in higher
eukaryotes, and currently there is no knowledge of a similar pro-
cess in yeast. In this process, a chaperone protein binds to a speciﬁc
target protein, causing it to unfold, allowing for direct transport
across the lysosomal membrane [12]. Microautophagy sequesters
cytoplasmic components, and delivers them for degradation by
the direct invagination or protrusion/septation of the lysosomal
or vacuolar membrane [13]. Macroautophagy, hereafter referred
to as autophagy, is the most well characterized process of the
three. Autophagy was ﬁrst studied in mammalian cells [14], but
the majority of the molecular components were initially elucidated
in yeast [15], and this review focuses on the yeast model system.
The morphological hallmark of autophagy is the de novo forma-
tion of the autophagosome, a double-membrane vesicle that
sequesters cytosol and organelles. The outer membrane of thechemical Societies. Published by E
).autophagosome fuses with the vacuole, releasing the inner mem-
brane, termed the autophagic body, into the lumen where it and
its contents are degraded [16]. Although autophagy’s primary role
in yeast is to respond to cellular stress, homeostatic and biosyn-
thetic functions have also been elucidated. For example, excess
peroxisomes are degraded by pexophagy, a selective type of
autophagy, when conditions make them superﬂuous [17]. In addi-
tion to pexophagy, there are other organelle-speciﬁc autophagy
pathways, such as mitophagy for mitochondria [18], and reticulo-
phagy for the endoplasmic reticulum [19]. Yeast cells also have
the cytoplasm to vacuole targeting (Cvt) pathway. The Cvt pathway
is responsible for the delivery of at least two hydrolases, a-man-
nosidase (Ams1) and aminopeptidase I (Ape1), to the vacuole.
Ape1 is synthesized in the cytosol as a proenzyme that is relatively
inactive. The Cvt pathway sequesters the precursor Ape1 into a Cvt
vesicle at the phagophore assembly site or PAS (‘‘phagophore” is
the term that describes the initial sequestering vesicle used in
autophagy-related pathways), using much of the same machinery
as autophagy, and delivers it into the vacuole where it is activated
by the removal of the propeptide [20,21]. Because of the similarity
between autophagy and the Cvt pathway, the Cvt pathway is con-
sidered to be a selective type of autophagy. This paper will review
the Cvt pathway and its principal cargo, precursor Ape1, in depth.2. Ape1 and the Cvt pathway
Ape1 is one of four aminopeptidases that hydrolyze leucine
substrates, identiﬁed in the yeast Saccharomyces cerevisiae [22].
Further characterization of the protein by subcellular fractionation
revealed it to be localized to the vacuole [23,24], and it appeared tolsevier B.V. All rights reserved.
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Fig. 1. Three main types of autophagy. There are three main types of autophagy:
chaperone-mediated autophagy, microautophagy, and macroautophagy. The sche-
matic depicts a mixture of these processes in lower and higher eukaryotes. For
example, the lysosome is much smaller than the fungal vacuole. Also, chaperone-
mediated autophagy has only been characterized in higher eukaryotes, whereas
microautophagy and macroautophagy are evolutionarily conserved. Macroauto-
phagy is the best-characterized pathway out of the three and the hallmark of this
process is the formation of a double-membrane vesicle that non-selectively
sequesters cytoplasmic components and delivers them to the lysosome or vacuole
for degradation and recycling of the cargo.
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Röhm originally concluded from western blot migration patterns
that Ape1 was glycosylated and thus transported to the vacuole
through a portion of the secretory pathway. However, the presence
of carbohydrates on Ape1 was never conﬁrmed and Klionsky et al.
show that it is not glycosylated; treatment with the glycosylation
inhibitor tunicamycin does not change the migration pattern of
Ape1 during SDS–PAGE, and the protein does not bind the lectin
concanavalin A [26]. Similar to many other vacuolar hydrolases,
Ape1 is synthesized as a zymogen (prApe1) and is processed in a
Pep4-dependent manner [22]. Precursor Ape1 maturation is nor-
mal in certain secmutants, which block the secretory pathway, fur-
ther indicating that prApe1 does not enter the endoplasmic
reticulum [26]. Yoshihisa and Anraku had indicated that another
vacuolar hydrolase, a-mannosidase (Ams1), enters the vacuole di-
rectly from the cytosol [27], and subsequent studies show that
Ams1 uses the same delivery mechanism as prApe1 [28]. This
alternative route is named the cytoplasm to vacuole targeting
pathway to distinguish it from the canonical pathway used by
most vacuolar hydrolases that transit through a portion of the
secretory pathway.
Precursor Ape1 has a half-life of maturation of approximately
45 min, which, coupled with its activation by cleavage of the
propeptide in the vacuole, makes it an ideal marker for the Cvt
pathway [26]. A mutagenesis screen used Ape1 to identify compo-
nents of this alternative vacuole transport pathway by isolating
mutants that accumulate prApe1. The authors found two comple-
mentation groups that are allelic to the previously identiﬁed vps
class B mutants that lack vacuolar acidiﬁcation. One complementa-
tion group is allelic to the gene encoding proteinase B, which acts
along with Pep4 in removal of the prApe1 propeptide, and the
remaining ﬁve groups were determined to be phenotypically dis-tinct from other known mutants. These mutants show a defect in
prApe1 maturation, but no defect in Prc1 maturation. The mutants
are namedatg7, atg8, atg9 and atg11 (the original names were cvt2,
cvt5, cvt6/cvt7 and cvt3/cvt9, respectively) [29]. Cellular fraction-
ation experiments show that in those mutants prApe1 is blocked
in delivery to the vacuole, so that it accumulates in the cytosolic
fraction [29]. The cvt mutants were further analyzed using an
in vitro import assay for prApe1 uptake. This assay radiolabels
spheroplasts in vivo prior to being lysed, so that the maturation
of newly synthesized prApe1 can be followed in vitro. From this as-
say it is determined that prApe1 maturation is time- and temper-
ature-dependent. It is also shown that the Cvt pathway requires
ATP, a functional vacuolar ATPase, and a GTP binding protein
[30]. Site-directed mutagenesis of the APE1 gene indicates an
important role for the propeptide region of prApe1 in the proper
targeting of the protein to the vacuole [31,32]. The predicted sec-
ondary structure of the propeptide region includes two a-helices
separated by a b-turn [33]. The ﬁrst a-helix is amphipathic with
both acidic and basic amino acids [31]. Random and site directed
mutations in the ﬁrst a-helix result in a defect in prApe1 matura-
tion and localization. Mutations in the propeptide region do not
prevent proper folding of prApe1, but mutations in the ﬁrst a-helix
do prevent association with a membrane. The mutagenesis screen
identiﬁed one key residue, lysine 12, which is especially important
for proper vacuolar localization. Mutations in the second a-helix
do not affect the kinetics of prApe1 maturation [31]. These data
indicate that the ﬁrst helix is responsible for targeting prApe1 to
the vacuole.
Two hypotheses were suggested for the vacuolar import of prA-
pe1. The ﬁrst suggested that prApe1 is transported across the vac-
uole membrane in an unfolded or partially unfolded state through
a vacuolar pore or channel, similar to the mechanism used in chap-
erone-mediated autophagy. The problem with this hypothesis is
that there is no morphological evidence for a pore complex in
the vacuole limiting membrane. The second hypothesis proposed
a vesicle-mediated transport mechanism [34]. This hypothesis
was supported by a study that examined the oligomeric state of
prApe1. Pulse-chase analysis shows that precursor Ape1 rapidly
oligomerizes into a homododecamer, which then assembles into
a higher order complex composed of multiple dodecamers (the
Ape1 complex) [35]. The oligomerization of prApe1 occurs in the
cytosol prior to associating with a membrane, and occurs indepen-
dent of the Atg proteins. Truncations in the C terminus inhibit olig-
omerization indicating that this region is responsible for
generating this higher order structure. Once assembled, the dode-
camer is not disassembled, eliminating the possibility of prApe1
entering the vacuole through a small pore in the vacuole mem-
brane, and ruling out translocation of the unfolded protein across
the membrane as occurs in chaperone-mediated autophagy [35].
Interestingly, later studies show that Ams1, the other identiﬁed
cargo of the Cvt pathway, also exists as an oligomer [28], suggest-
ing that one function of this pathway is the transport of hydrolases
that assemble into oligomeric complexes.
Vesicle-mediated transport of prApe1 is conﬁrmed using frac-
tionation and immunoelectron microscopy experiments. Subcellu-
lar fractionation reveals a pool of prApe1 that is associated with a
non-vacuolar membrane compartment [34,36]. In the vps18 mu-
tant, that inhibits fusion at the vacuole, prApe1 accumulates in a
non-vacuolar membrane compartment, suggesting that prApe1 is
transported to the vacuole inside a vesicle [34]. The prApe1P22L
mutant is mutated in the b-turn of the propeptide region. This mu-
tant has increased membrane-binding afﬁnity, but inhibits subse-
quent steps of the transport process. In cells expressing this
mutant, prApe1 co-fractionates with membrane that lacks vacuole
markers [34]. Immunoelectron microscopy further conﬁrms that
prApe1 ﬁrst binds to, and is then encapsulated by, a double-mem-
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Fig. 2. Classiﬁcation of Atg proteins according to function. Autophagy-related (Atg)
proteins can be classiﬁed according to their role in selective and non-selective
autophagy. There are 17 Atg proteins that are required for both types, and these are
named the core machinery. Selective autophagy is represented by the cytoplasm to
vacuole targeting (Cvt) pathway, mitophagy and pexophagy.
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cvt17D) cells that are defective in the breakdown of Cvt bodies,
cytosolic and subvacuolar prApe1-containing vesicles are visual-
ized [34,36].
Once prApe1 is oligomerized and bound to a membrane is must
be sequestered inside a Cvt vesicle of between 140 and 160 nm in
diameter [37]. Electron micrographs illustrate that the Cvt vesicle
forms near the vacuole at the PAS and apparently excludes all cyto-
solic components to selectively isolate prApe1 [36]. The formation
of the Cvt vesicle requires the t-SNARE Tlg2 and the Sec1 homolog
Vps45 [38]. Baba et al. were able to visualize the steps leading to
fusion of the Cvt vesicle with the vacuole membrane using immu-
noelectron microscopy of pep4D cells [36]. The Cvt vesicle’s outer
membrane fuses with the vacuole, leaving the inner membrane ex-
posed to the lumen. Fusion requires the same machinery needed
for other vesicle fusion events at the vacuole including the Q-
SNAREs Vam3 and Vti1, the docking protein Vps18, and the rab
GTPase Ypt7 [37]. This process is morphologically similar to non-
selective autophagy. Both processes require a double-membrane
vesicle to sequester cargo and the vesicle fusion machinery to fuse
the outer membrane of the sequestering vesicle with the vacuole,
which results in the release of the inner membrane and its con-
tents in the vacuole lumen; in the case of autophagy, the contents
are degraded and the breakdown products are released back into
the cytosol, whereas the cargo of the Cvt pathway are resident
hydrolases that function in the vacuole lumen [20]. The genetic
screens for autophagy and Cvt pathway mutants reveal substantial
overlap between the molecular components [20,21]. This knowl-
edge changed the direction of study of the Cvt pathway to focus
more on the differences and similarities it has with autophagy.3. Core machinery required for selective and non-selective
autophagy
Several screens were carried out almost simultaneously for mu-
tants defective in selective and non-selective types of autophagy,
which resulted in the use of multiple names for the corresponding
genes. In 2003, these genes were uniﬁed into the autophagy-related
(ATG) nomenclature [39]. Currently, there are 33 ATG genes, with 17
making up the core machinery required for both the Cvt pathway
and autophagy. The 17 core ATG genes can be classiﬁed into four
groups based upon their function. The ﬁrst group includes Atg9
and factors involved in its cycling, which particularly include the
Atg1 protein kinase complex [40], the second includes the phospha-
tidylinositol 3-kinase (PtdIns3K) complex [41], the third group in-
cludes the ubiquitin-like (Ubl) protein system [42,43], and the
fourth group is comprised of proteins that act at the last stages of
autophagy, vesicle breakdown and efﬂux of the cargo degradation
products back into the cytosol. The core Atg proteins function at
various stages during the autophagy-related pathways, which can
be broken down into several steps: (1) The phagophore nucleates
at the PAS, a perivacuolar structure that is the site of sequestering
vesicle formation in yeast. (2) The phagophore expands to seques-
ter the cargo. (3) The phagophore closes creating the double-mem-
brane autophagosome or Cvt vesicle. (4) The autophagosome or Cvt
vesicle fuses with the vacuole, releasing the inner vesicle that is
now termed an autophagic body or Cvt body. (5) The autophagic
body and its contents are degraded by vacuolar hydrolases, and
the products are released into the cytosol by various permeases;
the Cvt body is also broken down, and its cargos are matured (in
the case of prApe1) and carry out their functions in the vacuole lu-
men. The differences and similarities in the Atg proteins needed for
autophagy and selective autophagy are shown in Fig. 2.
The Atg1 protein kinase complex acts at an initial step of auto-
phagosome formation (and probably at later steps as well). In addi-tion to Atg1, the kinase complex consists of Atg11, Atg13, Atg17,
Atg20, Atg24, Atg29, and Atg31, not all of which are considered
‘‘core” components. Atg1 is a Ser/Thr kinase whose activity in-
creases upon starvation, and this protein is essential for autophagy
[40,44]. In addition, the Tor signaling pathway negatively regulates
autophagy through the Atg1 kinase complex [45]. The Tor complex
1 (TORC1) is a nutrient sensor that is active during periods of read-
ily available nutrients [46]. Parallel to TORC1 is the cyclic AMP
(cAMP)-dependent protein kinase A (PKA) [47,48]. Both are
responsible for the hyperphosphorylation of Atg13 during nutrient
rich conditions. In response to starvation conditions, TORC1 is
inhibited, resulting in the partial dephosphorylation of Atg13,
which may allow the protein to associate with Atg1 with greater
afﬁnity, subsequently resulting in an increase in Atg1 kinase activ-
ity [40,49,50]. A second regulatory complex that modulates Atg1
kinase activity is the Atg17–Atg29–Atg31 complex. Atg17, Atg29
and Atg31 form a ternary complex in response to starvation
conditions. The Atg17–Atg29–Atg31 complex has dual roles; it
associates with Atg1, inducing Atg1 kinase activity, and it is also
responsible for recruiting other core Atg proteins to the PAS by
acting as an organizing scaffold [51,52]. The functions of Atg20
and Atg24 are not understood, whereas Atg11 serves as a scaffold
protein that is required for most types of selective autophagy
[53,54].
S. cerevisiae has only one phosphatidylinositol 3-kinase, Vps34
[55]. Vps34 associates with two different complexes. The ﬁrst com-
plex consists of Vps34, Atg6 and Atg14 and is speciﬁc for autoph-
agy, whereas the second complex contains Vps38 instead of
Atg14, and is required for vacuolar protein sorting by the endo-
some [41,56]. Atg14 targets the Vps34 kinase complex to the PAS
[56]. Accordingly, Atg14 is responsible for localizing PtdIns(3)P-
binding proteins, including Atg18 (which also binds Atg2), to the
PAS [57]. Atg18 binds PtdIns(3)P through an FRRY motif. When this
motif is mutated to FTTY, Atg18 no longer binds to PtdIns(3)P
resulting in a block in both the Cvt pathway and autophagy. This
mutant does not affect binding to Atg2, but both Atg2 and the
PtdIns(3)P-binding capability of Atg18 are required to localize
the complex to the PAS [58]. Relatively little is known about the
functions of the Atg18–Atg2 complex, but it is involved in the cy-
cling of Atg9 between peripheral structures and the PAS [59].
Atg9 is a self-associating integral membrane protein that localizes
to peripheral (i.e., non-PAS) punctate structures, and cycles to and
from the PAS. Atg9 is the only integral membrane protein that is
absolutely required for the initial stages of autophagy and the
Cvt pathway, and is therefore thought to play a role in trafﬁcking
membrane from a donor source(s) to the PAS [60]. Atg9 accumu-
lates at the PAS in atg1D, atg2D and atg18D mutant strains, indi-
cating a role for these proteins in the retrograde (i.e., from the
PAS to the peripheral sites) transport of Atg9.
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There are two separate yet related conjugation systems that are
needed for autophagy. The ﬁrst is the Atg8 conjugation system.
Atg8 is conjugated to phosphatidylethanolamine (PE) and associ-
ates with the phagophore and autophagosome [43]. Atg8 expres-
sion is increased under starvation conditions [38,61], and this
increase is implicated in regulating the size of the autophagosome;
when the expression level of Atg8 is artiﬁcially decreased in starva-
tion conditions, the size of the autophagosome is smaller
compared to the wild-type phenotype [62]. Atg8 contains a C-ter-
minal arginine residue that is removed by the cysteine protease
Atg4 [38]. Atg8 is then conjugated to PE via the ultimate glycine
residue through the actions of an E1 ubiquitin activating enzyme
homolog, Atg7, and an E2 ubiquitin conjugating enzyme analog,
Atg3 [63,64]. Atg8–PE is initially located on the inner and outer
membranes of the phagophore. Upon completion of the auto-
phagosome or Cvt vesicle, Atg8 is removed particularly from the
PE in the outer membrane by a second Atg4-dependent cleavage
[38]. The remaining Atg8–PE on the inner membrane is delivered
to the vacuole as part of the autophagic (or Cvt) body and is de-
graded. The association of Atg8 with the inner membrane of the
phagophore may play a role in cargo tethering in the Cvt pathway;
Atg8 binds the prApe1 receptor Atg19, which may allow the
sequestering membrane to enwrap the cargo [64].
The second conjugation system consists of the Atg12AAtg5
complex. Atg12 is conjugated to Atg5 by the formation of an irre-
versible isopeptide bond between a C-terminal glycine residue of
Atg12 and a speciﬁc lysine residue of Atg5 [42]. Similar to the
Atg8 conjugation system, Atg12 is conjugated to Atg5 through
the actions of Atg7, and a different E2-like enzyme, Atg10
[63,64]. The Atg12AAtg5 complex associates with the multimeric
protein Atg16; Atg5 binds non-covalently with the N terminus of
Atg16 [65,66]. Atg16 is responsible for targeting the multimeric
complex to the PAS [65]. The Atg12AAtg5–Atg16 complex appears
to play some role in Atg8 conjugation to PE in vivo. Atg12AAtg5–
Atg16 may act as an E3 enzyme by interacting with Atg3 and
enhancing its E2-like activity, and Atg16 appears to dictate in part
the location of Atg8 conjugation [67–69].
The last group of core proteins consists of those involved in the
ﬁnal stages of autophagy. At present, there are only two Atg pro-
teins in this group, Atg15 and Atg22. Atg15 is a putative lipase that
is needed for breakdown of the Cvt and autophagic bodies [70,71],
whereas Atg22 is an amino acid permease in the vacuolemembrane
[72]. These components are critical for some types of autophagy
such as starvation-induced non-selective autophagy; the cell can-
not survive without degradation of the autophagosome cargo and
release of the breakdown products back into the cytosol for reuse.
One question that remains to be answered is how the core
machinery is able to switch from creating the smaller, and selective
Cvt vesicles to the larger, non-selective autophagosomes upon
nutrient starvation. It was ﬁrst hypothesized that the phosphoryla-
tion state of Atg13 may act as the molecular switch to turn off the
Cvt pathway and turn on autophagy since Atg13 is hyperphospho-
rylated during nutrient rich conditions and is rapidly dephospho-
rylated upon starvation [50]. However, the Cvt pathway and
autophagy are not mutually exclusive processes, and therefore
the molecular switch must be more complicated than just the
dephosphorylation of Atg13 [73]. Another candidate for the molec-
ular switch is the Atg17–Atg29–Atg31 ternary complex, which
plays a role along with Atg1 and Atg13 in the nucleation of the
PAS under starvation conditions. Cheong et al. show that in the
atg17D mutant pexophagy is completely blocked and autophagy
is partially defective while the Cvt pathway is unaffected, suggest-
ing a role for Atg17 in controlling the magnitude of the autophagic
response [74]. The Atg17–Atg29–Atg31 autophagy-speciﬁc com-
plex could regulate the size of the autophagosome without affect-ing the Cvt vesicle. In addition, during nutrient rich conditions,
Atg11, which is not needed for non-selective autophagy, is respon-
sible for the organization of the PAS [53]. This suggests that the
molecular switch between the two pathways is related to the ac-
tions of the Atg1–Atg13–Atg17(–Atg29–Atg31) starvation complex
versus the Cvt pathway-speciﬁc protein Atg11. More research
needs to be done to elucidate the mechanics of this proposed
switching complex.4. Speciﬁcity in the Cvt pathway
Precursor Ape1 is preferentially targeted to the vacuole in both
the Cvt pathway and autophagy, suggesting a speciﬁc targeting
mechanism. A receptor for prApe1 was proposed when it was
determined that prApe1 transport to the vacuole by the Cvt path-
way is speciﬁc and saturable [75]. Two groups simultaneously dis-
covered that Atg19 (originally Cvt19) has all of the characteristics
needed to be a receptor for prApe1 in Cvt transport [75,76]. The
protein was ﬁrst identiﬁed in a genome wide yeast two-hybrid
screen initiated to identify protein–protein interactions between
full-length open reading frames predicted from the S. cerevisiae
genome sequence [77]. Further characterization of the protein re-
vealed that Atg19 is needed for the stabilization of prApe1 binding
to the Cvt vesicle membrane, and that in atg19D cells prApe1 mat-
uration is inhibited while autophagy is not affected [75]. In addi-
tion, Atg19 binds to prApe1 in a propeptide-dependent manner,
suggesting that the propeptide region is responsible for the recog-
nition of prApe1 by the Cvt pathway machinery [75]. Finally, Atg19
is a peripheral membrane protein that localizes to the PAS, and its
half-life is consistent with that of prApe1 maturation. Atg19 has an
expression level stoichiometric with prApe1 and it is delivered to
the vacuole along with prApe1 [75]. Consistent with the Cvt path-
way transporting both prApe1 and Ams1 to the vacuole, Atg19 is
required for Ams1 vacuolar localization [28]. The binding domains
for prApe1 and Ams1 on Atg19 are separate and therefore Atg19 is
capable of delivering both prApe1 and Ams1 to the vacuole in the
same Cvt vesicle [77]. The receptor-mediated Cvt pathway is illus-
trated in Fig. 3.
The prApe1-Atg19 complex (deﬁned as the Cvt complex) is
transported to the PAS through a mechanism that is dependent
on Atg11 [78]. Atg11 speciﬁcally recognizes and binds a C-terminal
domain of Atg19 [78], and this interaction is independent of the
cargo proteins [79]; immunoprecipitation experiments show that
Atg11 and Atg19 coprecipitate both in wild-type and ape1D cells
[79]. The interaction between Atg11 and Atg19 is critical for the
proper localization of the Cvt complex to the PAS, because cells
lacking Atg11 show mislocalization of prApe1 and Atg19, as well
as a defect in prApe1 maturation [78]. In addition, Atg11 localiza-
tion is dependent upon both Atg19 and prApe1, suggesting that
Atg11 associates with the Cvt complex prior to PAS localization
[78,79]. These ﬁndings indicate that Atg11 is involved in the trans-
port of the Cvt complex to the PAS. Proper localization of the Cvt
complex to the PAS is also dependent upon the Vps53 (VFT) teth-
ering complex [80]. The tethering complex is required for Cvt ves-
icle formation but not for autophagy, suggesting that the
membrane source for Cvt vesicle and autophagosome formation
may be, at least in part, different. The VFT complex is composed
of four components, Vps51, Vps52, Vps53 and Vps54. This complex
works in conjunction with Vps45, and the Q-SNAREs Tlg1 and Tlg2,
to mediate Cvt vesicle formation [80]. In cells lacking components
of the VFT complex, Atg19 and prApe1 are no longer transported to
the PAS, but the defect in prApe1 maturation is reversed upon star-
vation [80]. Subsequent studies further suggest that the VFT com-
plex plays a role in Cvt vesicle formation by facilitating the
transport of Atg9 to the PAS [81].
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Ape1
Complex
Cvt Complex
Ams1 Atg19
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Fig. 3. Cvt vesicle formation. Precursor Ape1 is a proenzyme that is synthesized in the cytosol, and rapidly oligomerizes to form a homododecamer. The dodecamer further
organizes into a higher order structure termed the Ape1 complex. The receptor protein, Atg19, then binds to the Ape1 complex forming the Cvt complex. The Ams1 oligomer
is also able to bind Atg19 and can be incorporated into the same Cvt complex. Atg11 binds to Atg9 and transports the Cvt complex to the PAS. At the PAS the Cvt complex
binds to the expanding phagophore membrane through an interaction between Atg19 and Atg8APE. Transport of the Cvt complex to the PAS and the expansion of the
phagophore require the actin cytoskeleton and the VFT complex, respectively; delivery of membrane to the expanding vesicle likely involves cycling of Atg9. The phagophore
membrane expands around the Cvt complex (excluding bulk cytoplasm) forming the Cvt vesicle.
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process. Actin and the actin-binding complex Arp2/3 are required
for the Cvt pathway. Cells treated with the actin-disrupting drug
latrunculin A show a defect in prApe1 maturation, whereas the
drug has no affect on autophagy, suggesting that the actin cyto-
skeleton is only critical for the Cvt pathway [82]. Further analysis
by ﬂuorescence microscopy in cell lines with speciﬁc actin mu-
tants, suggests that the actin cytoskeleton is required for the local-
ization of the Cvt complex and Atg9 to the PAS; however,
disruption of actin does not affect the ability of the Cvt complex
to bind to a membrane [82]. It is hypothesized that the actin cyto-
skeleton acts as a track to guide cargos to the PAS, and that Atg11 is
the protein that binds the cargo to actin, whereas the Arp2/3 com-
plex could act as a motor that drives the Cvt complex to the PAS
[83].
The localization of the Cvt receptor complex to the PAS is essen-
tial for the proper organization of the PAS and Cvt vesicle forma-
tion. Without any component of the Cvt complex (and Atg11),
other Atg proteins do not efﬁciently localize to the PAS [54].
Atg11 is the critical component for proper PAS organization during
vegetative growth conditions, and the expression level of Atg11
correlates directly with the capacity of the Cvt pathway [84].
Though the C terminus of Atg11 is involved in binding to Atg19,there are other regions in Atg11 that are involved in forming com-
plexes with other Atg proteins including its own self-interaction
[79]. For example, Atg11 interacts with Atg9 to allow the delivery
of the latter to the PAS [85], and Atg11 interacts with the Atg1–
Atg13 kinase complex [79]. Likely as a result of its scaffold proper-
ties, the overexpression of Atg11 causes an increase in the amount
of Atg8 and Atg9 recruited to the PAS. This results in the formation
of more Cvt vesicles during nutrient rich conditions [84]. All of this
evidence indicates a critical role for Atg11 in PAS organization and
the formation of Cvt vesicles.
Atg19 interacts with Atg11 to transport the Cvt complex to the
PAS, once at the PAS Atg19 interacts with Atg8. Atg8 plays two
roles in the Cvt pathway; it is responsible for regulating vesicle for-
mation, and is helps mediate the sorting of selective cargo by act-
ing as a tether. The interaction with Atg19 is essential for Atg8’s
role in tethering the Cvt complex to the phagophore [84]. The
Cvt pathway is blocked in atg8D cells at the step of vesicle forma-
tion; precursor Ape1 accumulates and is protease accessible, but
can still associate with membranes in the atg8D mutant [52]. Ho
et al. were able to isolate these two functions in the sequence of
Atg8. They determined that the residues Arg28, Tyr49 and Leu50
are involved in both vesicle formation and cargo selection, whereas
Lys48 and Leu55 are only involved in vesicle formation [86]. It is
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the membrane to expand exclusively around the Cvt complex [54].
Atg11 is not required for non-selective autophagy, and hence
has been termed Cvt-speciﬁc; however, Atg11 is also required for
other types of selective autophagy. Other Atg proteins that are
not required for non-selective autophagy include Atg20, Atg21,
and Atg24. These latter proteins are phosphoinositide-binding pro-
teins. Atg20 and Atg24 bind PtdIns(3)P through a phox homology
(PX) domain and are dependent upon Atg14 and the PtdIns3K com-
plex for proper localization [87]. Mutations in the PX domain of
either protein prevent their localization at the PAS and partially
block prApe1 maturation. Mutations in the PX domains of both
proteins result in a complete block of the Cvt pathway. This sug-
gests that the interaction between Atg20 and Atg24 offers partial
complementation for a mutation in one of these two components
[87]. Atg21 is similar to Atg18 in that it binds PtdIns(3)P, and is re-
quired for Cvt vesicle formation [58]. In atg21D cells, not only do
Atg8 and Atg5 fail to localize to the PAS, there is also an observable
decrease in Atg8 lipidation [58]. These proteins provide speciﬁcity
for the role of the PtdIns3K complex in the Cvt pathway, and pre-
sumably other types of selective autophagy.5. The Cvt pathway and selective autophagy require speciﬁcity
factors
Selective autophagy is mediated by a cargo receptor and a spec-
iﬁcity factor (adaptor) that together connect the cargo to the core
autophagy machinery. As discussed previously, the cargo receptor
and the speciﬁcity factor for the Cvt pathway are Atg19 and Atg11,
respectively. Atg19 acts in two capacities; it ﬁrst binds the cargo
and transports it to the PAS through an interaction with Atg11,
and second, it interacts with Atg8, a component of the core autoph-
agy machinery, to aid in the formation of the Cvt vesicle. Atg19
interacts with Atg8 through a WXXL motif [88]. The WXXL motif
has an extended b conformation and forms an intermolecular par-
allel b-sheet with b2 of Atg8. The WXXL motif of Atg19 is followed
by acidic residues, which, with the motif, are required for binding
to Atg8 [88]. The binding pocket for the WXXL motif of Atg8 is cru-
cial only for the Cvt pathway and not non-selective autophagy,
indicating that this interaction is speciﬁc only for selective autoph-
agy. The WXXL binding pocket of Atg8 is highly conserved in high-
er eukaryotes [88]. The mammalian adaptor protein p62/SQSTM1,
which binds ubiquitin, also contains a WXXL motif that is respon-
sible for binding to the mammalian homolog of Atg8, LC3. These
ﬁndings suggest a possible fundamental mechanism responsible
for selective autophagy. Along these lines, two additional selective
autophagy receptors with WXXL motifs have recently been identi-
ﬁed in mammalian cells, NBR1 and Nix. Similar to p62, NBR1 con-
tains both a ubiquitin binding domain and the WXXL LC3 binding
domain, also termed the LC3-interacting region (LIR). NBR1 is in-
volved in the clearance of ubiquitinated aggregates [89], whereas
Nix plays a role in the selective clearance of mitochondria by
autophagy (mitophagy) during reticulocyte maturation [90,91].
In the yeast S. cerevisiae, mitophagy is mediated through the
receptor protein Atg32. Atg32 was ﬁrst identiﬁed in a genomic
screen for yeast mutants defective in mitophagy and it is not re-
quired for non-selective autophagy or the Cvt pathway [92].
Atg32 is located in the outer membrane of the mitochondria with
its N terminus in the cytosol and the C terminus in the intermem-
brane space. Similar to Atg19, Atg32 interacts with both Atg11 and
Atg8 as conﬁrmed by yeast two-hybrid and co-immunoprecipita-
tion experiments. Atg32 interacts with Atg11 to recruit mitochon-
dria to the PAS. Atg32 also contains a WXXL domain on its N
terminus, which is responsible for binding to Atg8, and mutation
of the WXXL domain blocks binding to Atg8, but not to Atg11[93]. The binding of Atg32 to Atg8 is required for the complete
sequestration of mitochondria by the phagophore [92,93]. These
observations suggest that Atg32 is a key receptor protein needed
for mitophagy.
The selective removal of peroxisomes by autophagy (pexo-
phagy) has mainly been studied in methylotrophic yeast, including
Pichia pastoris. The P. pastoris protein PpAtg30 has been identiﬁed
as the receptor for pexophagy. It was originally discovered in a
screen of a collection of micropexophagy mutants, and was identi-
ﬁed as a pexophagy-speciﬁc mutant; it is not required for the Cvt
pathway or non-selective autophagy. PpAtg30 overexpression is
able to stimulate pexophagy even under non-pexophagy inducing
conditions. PpAtg30 binds to peroxisomes by interacting with the
peroxins, PpPex3 and PpPex14, and it transiently associates with
the PAS during pexophagy. PpAtg30 binds to PpAtg11 and PpAtg17,
connecting the peroxisome to the core autophagy machinery.
However, PpAtg30 does not contain a WXXL domain, and therefore
does not interact with PpAtg8 [94]. It will be interesting to see if
future studies can determine if there is an intermediary protein
that links PpAtg30 to PpAtg8.
A recurring theme is apparent in selective autophagy. The cargo
must ﬁrst be recognized by a receptor protein, which is Atg19 for
the Cvt pathway, Atg32 for mitophagy, and PpAtg30 for pexo-
phagy. The receptor protein must then be able to bind an adaptor
protein that connects the cargo to the core autophagy machinery.
In yeast, Atg11 (and PpAtg11) acts as the adaptor protein. It binds
receptor proteins and uses actin to transport the cargo to the PAS,
and is responsible for the organization of the PAS during selective
autophagy. Once at the PAS, the cargo protein, at least in the case of
the Cvt pathway and mitophagy, is able to bind Atg8 via the recep-
tor. This mechanism appears to be conserved in higher eukaryotes
through the WXXL binding domain.6. Conclusions
The Cvt pathway is the best-characterized type of selective
autophagy and therefore stands as a model for how speciﬁc cargos
are delivered to the vacuole by the autophagy machinery. The Cvt
pathway has only been characterized in yeast, speciﬁcally S. cerevi-
siae and P. pastoris, and is not evolutionarily conserved [95]. Even
in fungi, there are certain differences, in that P. pastoris uses the
two proteins PpAtg26 and PpAtg28 [96]; S. cerevisiae Atg26 is not
involved in autophagy, and there is no ortholog of PpAtg28. De-
spite all of this, the study of the Cvt pathway can be beneﬁcial
for identifying and understanding selective types of autophagy in
higher eukaryotes.
The study of selective autophagy should provide important
information for future research related to human diseases. For
example, selective autophagy is implicated in the response to path-
ogen infection; certain pathogens, including the herpes simplex
virus, can be selectively degraded by xenophagy [97]. This process
recognizes invading pathogens and sequesters them within auto-
phagosomes, indicating a role for selective autophagy in innate
immunity [5,97]. Little is known about this process, but Thursten
et al. show that in human cells the protein NDP52 may act as a
receptor by recognizing ubiquitin-coated Salmonella, and recruit-
ing LC3 to the bacteria [98]. Selective autophagy also plays a key
role in the prevention of neurodegenerative disorders. Huntington,
Alzheimer, Parkinson and Creutzfeldt-Jakob diseases, are the result
of toxic neuropeptides that accumulate and form large protein
aggregates [99]. Mouse models show that autophagy can prevent
neurodegeneration by degrading aggregate-prone proteins before
they can damage neurons. The degradation of these protein aggre-
gates depends on p62, which may act similar to Atg19 as noted
above [100,101]. The basis for speciﬁcity in the different types of
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between the types of selective autophagy occurring in higher
eukaryotes and the yeast Cvt pathway are readily apparent. These
pathways require both a speciﬁcity factor/adaptor and a receptor.
The receptor in many cases contains a WXXL or LIR domain that
is able to bind Atg8/LC3, connecting the cargo to the core autoph-
agy machinery. Future studies using the Cvt pathway as a model
may be able to identify receptors and speciﬁcity factors for selec-
tive autophagy pathways in higher eukaryotes. Defects in selective
autophagy can result in the accumulation of damaged proteins and
organelles that are associated with various diseases. Thus, being
able to manipulate selective types of autophagy may have thera-
peutic potential for a range of human pathologies.
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